These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 4032097)

  • 21. Outcome of pregnancy in women with type 1 diabetes intensively treated with continuous subcutaneous insulin infusion or conventional therapy. A case-control study.
    Giménez M; Conget I; Nicolau J; Pericot A; Levy I
    Acta Diabetol; 2007 Mar; 44(1):34-7. PubMed ID: 17357884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
    Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
    Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AADE position statement: education for continuous subcutaneous insulin infusion pump users. American Association of Diabetes Educators.
    Diabetes Educ; 1997; 23(4):397-8. PubMed ID: 9305004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depression and anxiety symptoms in diabetic patients on continuous subcutaneous insulin infusion (CSII).
    Reichel A; Schwarz J; Schulze J; Licinio J; Wong ML; Bornstein SR
    Mol Psychiatry; 2005 Nov; 10(11):975-6. PubMed ID: 16077680
    [No Abstract]   [Full Text] [Related]  

  • 25. Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness.
    Radermecker RP; Scheen AJ
    Diabetes Metab Res Rev; 2004; 20(3):178-88. PubMed ID: 15133748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Continuous subcutaneous insulin infusion; the first decade].
    Doorenbos H
    Ned Tijdschr Geneeskd; 1987 Jan; 131(3):91-3. PubMed ID: 3821988
    [No Abstract]   [Full Text] [Related]  

  • 27. [Nursing of diabetic patients treated by continuous subcutaneous insulin infusion].
    Li YQ; Wang DQ
    Zhonghua Hu Li Za Zhi; 1985 Aug; 20(4):215-6. PubMed ID: 3849992
    [No Abstract]   [Full Text] [Related]  

  • 28. When to consider continuous subcutaneous insulin infusion (CSII).
    Drug Ther Bull; 1987 Apr; 25(7):25-8. PubMed ID: 3569048
    [No Abstract]   [Full Text] [Related]  

  • 29. Diet for insulin-dependent diabetic patients on continuous subcutaneous insulin infusion (CSII) treatment.
    Chantelau E; Sonnenberg GE; Best F; Berger M
    Diabetes Care; 1984; 7(3):301-2. PubMed ID: 6734399
    [No Abstract]   [Full Text] [Related]  

  • 30. [Portable insulin infusers].
    Souchon E; Schabanel H
    Soins; 1985 Aug; (459-460):37-40. PubMed ID: 3854532
    [No Abstract]   [Full Text] [Related]  

  • 31. Hyperkalaemia after interruption of CSII.
    Pickup JC
    Diabetologia; 1986 Nov; 29(11):823-4. PubMed ID: 3817340
    [No Abstract]   [Full Text] [Related]  

  • 32. Another complication associated with CSII systems.
    Romero GS; Clarke WL
    Diabetes Care; 1988 Apr; 11(4):370. PubMed ID: 3402297
    [No Abstract]   [Full Text] [Related]  

  • 33. CSII: Scale units to insulin units.
    Wilson DP; Endres RK
    Diabetes Care; 1983; 6(6):621. PubMed ID: 6653323
    [No Abstract]   [Full Text] [Related]  

  • 34. Technological aspects of CSII.
    Rothwell D
    Diabet Med; 1984 May; 1(1):32-4. PubMed ID: 6242773
    [No Abstract]   [Full Text] [Related]  

  • 35. Pros and cons of continuous subcutaneous insulin infusion.
    Watkins PJ
    Br Med J (Clin Res Ed); 1985 Mar; 290(6469):655-6. PubMed ID: 3918703
    [No Abstract]   [Full Text] [Related]  

  • 36. Continuous subcutaneous insulin infusion and neuropathy in older people.
    Rigalleau V; Bertrand A; Rojubally S; Majchrzak C; Bocock O; Foussard N; Monlun M; Blanco L; Mohammedi K
    Diabet Med; 2020 Jul; 37(7):1208-1209. PubMed ID: 32276296
    [No Abstract]   [Full Text] [Related]  

  • 37. [Detection and prevention of the malfunction of an insulin dosing device under clinical conditions].
    Dreval' AV; Postoiuk NI; Galitskiĭ AB; Liashchenko AM
    Probl Endokrinol (Mosk); 1991; 37(2):39-40. PubMed ID: 1857700
    [No Abstract]   [Full Text] [Related]  

  • 38. Continuous subcutaneous insulin infusion-an opportunity for better care but not a "magic pill".
    Cahn A; Roitman E; Aharon-Hananel G; Raz I
    Endocrine; 2017 Apr; 56(1):4-6. PubMed ID: 28039560
    [No Abstract]   [Full Text] [Related]  

  • 39. Problems with insulin syringes.
    Barbosa J
    Diabetes Care; 1982; 5(6):644-5. PubMed ID: 6927733
    [No Abstract]   [Full Text] [Related]  

  • 40. Exercise: a vital component for patients on the Biostator.
    Summers S
    Diabetes Educ; 1984; 10(2):22-4. PubMed ID: 6564950
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.